Yap, T. A., Alhalabi, O., Lu, Y., Mancini, B. R., Kulkarni, H. R., Plichta, K., Castaneda, S. A., Almaguel, F., Yeh, R., Reddy, R., Benjamin, D. J., Tripathi, A., Kuo, P. H., Huang, J., Horton, J. K., Galsky, M. D. (2026). [ 225 Ac]Ac-AKY-1189, a Nectin-4 targeted radiopharmaceutical, in patients with previously treated locally advanced or metastatic solid tumors: Phase 1b Nectinium-2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps902